« Return to News | Drug Sponsors

J&J looking to acquire Synthes

Tuesday, April 19, 2011 11:21 AM

Johnson & Johnson is looking to acquire global medical device manufacturer Synthes in a deal that could be worth around $20 billion as reported in Pharma Times.

While Synthes indicated the company has been talking about a deal, no further comments have been made.

Synthes develops, manufactures and markets instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues, and currently employs nearly 11,500 people worldwide.

Last year, Synthes’ sales totaled $3.7 billion, making the company an attractive buy for J&J.

According to Vontobel analyst Carla Baenziger, a partnership between the two firms would double J&J's market share in spinal care to 30%, making it second only to MedTronic, and making it first in U.S. market for trauma with a share of around 57%, media reports note.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.